Advertisement

European Radiology

, Volume 18, Issue 11, pp 2370–2380 | Cite as

Magnetic resonance imaging of inflammatory breast carcinoma and acute mastitis. A comparative study

  • Diane M. Renz
  • Pascal A. T. Baltzer
  • Joachim Böttcher
  • Fady Thaher
  • Mieczyslaw Gajda
  • Oumar Camara
  • Ingo B. Runnebaum
  • Werner A. Kaiser
Breast

Abstract

The aim of this study was to evaluate the potential of magnetic resonance mammography (MRM) to distinguish inflammatory breast carcinomas (IBC) from acute mastitis (AM). This study compared MRM examinations of two selected groups of patients: 48 subjects with IBC and 42 patients with AM. No statistical differences were revealed between the two groups for morphology of masses and of non-mass-like enhancement, breast enlargement, diffuse skin thickening, abnormal nipple configuration, prominent vessels, and also for cutaneous/subcutaneous, perimamillar and diffuse oedema. However, initial and postinitial dynamic characteristics significantly differed between the two groups (p < 0.001). In IBC, more masses with a greater average size were detected (p < 0.05). The following morphological criteria were also observed more often in IBC (p < 0.05): T2-hypointensity of masses (77.5%/18.2%), blooming sign (62.5%/31.8%), infiltration of pectoralis major muscle (interruption of fat plane: 54.2%/16.7%; pathological enhancement: 33.3%/7.1%), perifocal (66.7%/33.3%), prepectoral (72.9%/31.0%) and intramuscular pectoral oedema (41.7%/7.1%). The main localisation of AM was subareolar, of IBC central or dorsal (p < 0.001). The discrimination between AM and IBC remains a diagnostic challenge because of overlapping imaging features. However, the combination of multiple dynamic and morphological MRM criteria seems to have the potential for a differential diagnosis.

Keywords

Inflammatory breast carcinoma Acute mastitis Breast infection MR mammography Morphology Dynamics 

Abbreviations

IBC

inflammatory breast carcinomas

AM

acute mastitis

MRM

magnetic resonance mammography

BI-RADS

breast imaging reporting and data system

ROI

region of interest

References

  1. 1.
    Crowe DJ, Helvie MA, Wilson TE (1995) Breast infection. Mammographic and sonographic findings with clinical correlation. Invest Radiol 30:582–587PubMedCrossRefGoogle Scholar
  2. 2.
    Bässler R (1997) Mastitis. Classification, histopathology and clinical aspects. Pathologe 18:27–36 DOI  10.1007/s002920050193 PubMedCrossRefGoogle Scholar
  3. 3.
    Hance KW, Anderson WF, Devesa SS, Young HA, Levine PH (2005) Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst 97:966–975 DOI  10.1093/jnci/dji172 PubMedCrossRefGoogle Scholar
  4. 4.
    Günhan-Bilgen I, Üstün EE, Memis A (2002) Inflammatory breast carcinoma: mammographic, ultrasonographic, clinical, and pathologic findings in 142 cases. Radiology 223:829–838 DOI  10.1148/radiol.2233010198 PubMedCrossRefGoogle Scholar
  5. 5.
    Lequin MH, van Spengler J, van Pel R, van Eijck C, van Overhagen H (1995) Mammographic and sonographic spectrum of non-puerperal mastitis. Eur J Radiol 21:138–142 DOI  10.1016/0720–048X(95)00699-Q PubMedCrossRefGoogle Scholar
  6. 6.
    Iglesias A, Arias M, Santiago P, Rodríguez M, Mañas J, Saborido C (2007) Benign breast lesions that simulate malignancy: magnetic resonance imaging with radiologic-pathologic correlation. Curr Probl Diagn Radiol 36:66–82 DOI  10.1067/j.cpradiol.2006.12.001 PubMedCrossRefGoogle Scholar
  7. 7.
    Lerebours F, Bieche I, Lidereau R (2005) Update on inflammatory breast cancer. Breast Cancer Res 7:52–58 DOI  10.1186/bcr997 PubMedCrossRefGoogle Scholar
  8. 8.
    Rieber A, Tomczak RJ, Mergo PJ, Wenzel V, Zeitler H, Brambs HJ (1997) MRI of the breast in the differential diagnosis of mastitis versus inflammatory carcinoma and follow-up. J Comput Assist Tomogr 21:128–132PubMedCrossRefGoogle Scholar
  9. 9.
    Fischer U, Vosshenrich R, von Heyden D, Knipper H, Oestmann JW, Grabbe E (1994) Inflammatory lesions of the breast: indication for MR-mammography? Rofo 161:307–311PubMedGoogle Scholar
  10. 10.
    Orel SG, Schnall MD (2001) MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 220:13–30PubMedGoogle Scholar
  11. 11.
    Kuhl CK (2007) Current status of breast MR imaging. Part 2. Clinical applications. Radiology 244:672–691 DOI  10.1148/radiol.2443051661 PubMedCrossRefGoogle Scholar
  12. 12.
    Kaiser WA, Zeitler E (1989) MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology 170:681–686PubMedGoogle Scholar
  13. 13.
    Heywang-Köbrunner SH, Viehweg P, Heinig A, Küchler C (1997) Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur J Radiol 24:94–108PubMedCrossRefGoogle Scholar
  14. 14.
    Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, Schild HH (1999) Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 211:101–110PubMedGoogle Scholar
  15. 15.
    Sherif H, Mahfouz AE, Oellinger H, Hadijuana J, Blohmer JU, Taupitz M, Felix R, Hamm B (1997) Peripheral washout sign on contrast-enhanced MR images of the breast. Radiology 205:209–213PubMedGoogle Scholar
  16. 16.
    Kuhl CK, Klaschik S, Mielcarek P, Gieseke J, Wardelmann E, Schild HH (1999) Do T2-weighted pulse sequences help with the differential diagnosis of enhancing lesions in dynamic breast MRI? J Magn Reson Imaging 9:187–196PubMedCrossRefGoogle Scholar
  17. 17.
    Fischer DR, Wurdinger S, Böttcher J, Malich A, Kaiser WA (2005) Further signs in the evaluation of magnetic resonance mammography: a retrospective study. Invest Radiol 40:430–435PubMedCrossRefGoogle Scholar
  18. 18.
    Malich A, Fischer DR, Wurdinger S, Böttcher J, Marx C, Facius M, Kaiser WA (2005) Potential MRI interpretation model: differentiation of benign from malignant breast masses. AJR Am J Roentgenol 185:964–970 DOI  10.2214/AJR.04.1073 PubMedCrossRefGoogle Scholar
  19. 19.
    Baum F, Fischer U, Vosshenrich R, Grabbe E (2002) Classification of hypervascularized lesions in CE MR imaging of the breast. Eur Radiol 12:1087–1092 DOI  10.1007/s00330–001–1213–1 PubMedCrossRefGoogle Scholar
  20. 20.
    Tomczak R, Rieber A, Zeitler H, Rilinger N, Kreienberg R, Brambs HJ (1996) The value of MR-mammography at 1.5 tesla in the differential diagnosis of non-puerperal mastitis and inflammatory breast carcinoma. Rofo 165:148–151PubMedGoogle Scholar
  21. 21.
    Belli P, Costantini M, Romani M, Pastore G (2002) Role of magnetic resonance imaging in inflammatory carcinoma of the breast. Rays 27:299–305PubMedGoogle Scholar
  22. 22.
    American College of Radiology (2003) Breast imaging reporting and data system (BI-RADS) atlas, 4th edn. American College of Radiology, Reston, VAGoogle Scholar
  23. 23.
    Fischer DR, Baltzer P, Malich A, Wurdinger S, Freesmeyer MG, Marx C, Kaiser WA (2004) Is the “blooming sign” a promising additional tool to determine malignancy in MR mammography? Eur Radiol 14:394–401 DOI  10.1007/s00330–003–2055–9 PubMedCrossRefGoogle Scholar
  24. 24.
    Renz DM, Baltzer PAT, Böttcher J, Facius M, Pfleiderer SOR, Gajda M, Camara O, Kaiser WA (2006) New signs of tumors in magnetic resonance imaging. Eur Radiol 16(Suppl5):E80–E82 DOI  10.1007/s10406–006–0187–0 Google Scholar
  25. 25.
    Friedman EP, Hall-Craggs MA, Mumtaz H, Schneidau A (1997) Breast MR and the appearance of the normal and abnormal nipple. Clin Radiol 52:854–861 DOI  10.1016/S0009–9260(97)80081–5 PubMedCrossRefGoogle Scholar
  26. 26.
    Kazama T, Nakamura S, Doi O, Suzuki K, Hirose M, Ito H (2005) Prospective evaluation of pectoralis muscle invasion of breast cancer by MR imaging. Breast Cancer 12:312–316 DOI  10.2325/jbcs.12.312 PubMedCrossRefGoogle Scholar
  27. 27.
    Mahfouz AE, Sherif H, Saad A, Taupitz M, Filimonow S, Kivelitz D, Hamm B (2001) Gadolinium-enhanced MR angiography of the breast: is breast cancer associated with ipsilateral higher vascularity? Eur Radiol 11:965–969 DOI  10.1007/s003300000668 PubMedCrossRefGoogle Scholar
  28. 28.
    Buadu LD, Murakami J, Murayama S, Hashiguchi N, Sakai S, Masuda K, Toyoshima S, Kuroki S, Ohno S (1996) Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 200:639–649PubMedGoogle Scholar
  29. 29.
    Furman-Haran E, Schechtman E, Kelcz F, Kirshenbaum K, Degani H (2005) Magnetic resonance imaging reveals functional diversity of the vasculature in benign and malignant breast lesions. Cancer 104:708–718 DOI  10.1002/cncr.21225 PubMedCrossRefGoogle Scholar
  30. 30.
    Sunderkötter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C (1994) Macrophages and angiogenesis. J Leukoc Biol 55:410–422PubMedGoogle Scholar
  31. 31.
    Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, Tognazzi K, Dvorak HF (1999) Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res 5:1041–1056PubMedGoogle Scholar
  32. 32.
    Taichman NS, Young S, Cruchley AT, Taylor P, Paleolog E (1997) Human neutrophils secrete vascular endothelial growth factor. J Leukoc Biol 62:397–400PubMedGoogle Scholar
  33. 33.
    Macéa JR, Fregnani JHTG (2006) Anatomy of the thoracic wall, axilla and breast. Int J Morphol 24:691–704CrossRefGoogle Scholar
  34. 34.
    Lee KW, Chung SY, Yang I, Kim HD, Shin SJ, Kim JE, Chung BW, Choi YA (2005) Inflammatory breast cancer: imaging findings. Clin Imaging 29:22–25PubMedGoogle Scholar
  35. 35.
    Haagensen CD (1986) Infections in the breast. In: Haagensen CD (ed) Diseases of the breast. 3rd edn. Saunders, Philadelphia, pp 384–393Google Scholar
  36. 36.
    Yilmaz E, Lebe B, Usal C, Balci P (2001) Mammographic and sonographic findings in the diagnosis of idiopathic granulomatous mastitis. Eur Radiol 11:2236–2240PubMedCrossRefGoogle Scholar
  37. 37.
    Rieber A, Nüssle K, Merkle E, Kreienberg R, Tomczak R, Brambs HJ (1999) MR mammography: influence of menstrual cycle on the dynamic contrast enhancement of fibrocystic disease. Eur Radiol 9:1107–1112PubMedCrossRefGoogle Scholar
  38. 38.
    Pfleiderer SOR, Sachse S, Sauner D, Marx C, Malich A, Wurdinger S, Kaiser WA (2004) Changes in magnetic resonance mammography due to hormone replacement therapy. Breast Cancer Res 6:R232–R238 DOI  10.1186/bcr779 PubMedCrossRefGoogle Scholar

Copyright information

© European Society of Radiology 2008

Authors and Affiliations

  • Diane M. Renz
    • 1
    • 4
  • Pascal A. T. Baltzer
    • 1
  • Joachim Böttcher
    • 1
  • Fady Thaher
    • 1
  • Mieczyslaw Gajda
    • 2
  • Oumar Camara
    • 3
  • Ingo B. Runnebaum
    • 3
  • Werner A. Kaiser
    • 1
  1. 1.Institute of Diagnostic and Interventional RadiologyFriedrich Schiller University JenaJenaGermany
  2. 2.Institute of PathologyFriedrich Schiller University JenaJenaGermany
  3. 3.Clinic of GynaecologyFriedrich Schiller University JenaJenaGermany
  4. 4.Institute of Diagnostic and Interventional Radiology, Gynaecological RadiologyFriedrich Schiller University JenaJenaGermany

Personalised recommendations